Indications | No |
---|---|
Thyromegaly | 931 (65%) |
Having established nodule > 1 cm | 143 (10%) |
Graves’ ophthalmopathy | 143 (10%) |
Anti thyroid resistance to therapy, anti thyroid adverse effects of therapy, the inability of an adequate antithyroid therapy | 215 (15%) |
Σ | 1432 (100%) |